TTM
$65.6B
YoY change
+1.2%
5Y CAGR
+9.4%
Peak year (FY2025)
$64.9B
Cumulative revenue
$1.23T
Revenue history chart for Merck & Co. (MRK) from 2016 to 2025
Latest: $64.9B
Revenue growth chart for Merck & Co. (MRK) from 2016 to 2025
Latest: +1.2%
Revenue history table for Merck & Co. (MRK) from 1985 to 2025
| FY2025 | $64.9B | +1.2% | +$758M | ||
| FY2024 | $64.2B | +6.7% | +$4.05B | ||
| FY2023 | $60.1B | +1.4% | +$832M | ||
| FY2022 | $59.3B | +21.7% | +$10.6B | ||
| FY2021 | $48.7B | +17.3% | +$7.19B | ||
| FY2020 | $41.5B | +6.1% | +$2.4B | ||
| FY2019 | $39.1B | -7.5% | -$3.17B | ||
| FY2018 | $42.3B | +5.4% | +$2.17B | ||
| FY2017 | $40.1B | +0.8% | +$315M | ||
| FY2016 | $39.8B | +0.8% | +$309M | ||
| FY2015 | $39.5B | -6.5% | -$2.74B | ||
| FY2014 | $42.2B | -4.1% | -$1.8B | ||
| FY2013 | $44B | -6.8% | -$3.23B | ||
| FY2012 | $47.3B | -1.6% | -$780M | ||
| FY2011 | $48B | +4.5% | +$2.06B | ||
| FY2010 | $46B | +67.7% | +$18.6B | ||
| FY2009 | $27.4B | +15.0% | +$3.58B | ||
| FY2008 | $23.9B | -1.4% | -$348M | ||
| FY2007 | $24.2B | +6.9% | +$1.56B | ||
| FY2006 | $22.6B | +2.8% | +$624M | ||
| FY2005 | $22B | -4.2% | -$961M | ||
| FY2004 | $23B | +2.2% | +$487M | ||
| FY2003 | $22.5B | +4.8% | +$1.04B | ||
| FY2002 | $21.4B | +1.2% | +$247M | ||
| FY2001 | $21.2B | -47.5% | -$19.2B | ||
| FY2000 | $40.4B | +23.4% | +$7.65B | ||
| FY1999 | $32.7B | +21.6% | +$5.82B | ||
| FY1998 | $26.9B | +13.8% | +$3.26B | ||
| FY1997 | $23.6B | +19.2% | +$3.81B | ||
| FY1996 | $19.8B | +18.9% | +$3.15B | ||
| FY1995 | $16.7B | +11.4% | +$1.71B | ||
| FY1994 | $15B | +42.6% | +$4.47B | ||
| FY1993 | $10.5B | +8.6% | +$836M | ||
| FY1992 | $9.66B | +12.3% | +$1.06B | ||
| FY1991 | $8.6B | +12.1% | +$931M | ||
| FY1990 | $7.67B | +17.1% | +$1.12B | ||
| FY1989 | $6.55B | +10.3% | +$611M | ||
| FY1988 | $5.94B | +17.4% | +$878M | ||
| FY1987 | $5.06B | +22.6% | +$932M | ||
| FY1986 | $4.13B | +16.4% | +$581M | ||
| FY1985 | $3.55B | — | — |
- FY2025$64.9B+1.2%
- FY2024$64.2B+6.7%
- FY2023$60.1B+1.4%
- FY2022$59.3B+21.7%
- FY2021$48.7B+17.3%
- FY2020$41.5B+6.1%
- FY2019$39.1B-7.5%
- FY2018$42.3B+5.4%
- FY2017$40.1B+0.8%
- FY2016$39.8B+0.8%
- FY2015$39.5B-6.5%
- FY2014$42.2B-4.1%
- FY2013$44B-6.8%
- FY2012$47.3B-1.6%
- FY2011$48B+4.5%
- FY2010$46B+67.7%
- FY2009$27.4B+15.0%
- FY2008$23.9B-1.4%
- FY2007$24.2B+6.9%
- FY2006$22.6B+2.8%
- FY2005$22B-4.2%
- FY2004$23B+2.2%
- FY2003$22.5B+4.8%
- FY2002$21.4B+1.2%
- FY2001$21.2B-47.5%
- FY2000$40.4B+23.4%
- FY1999$32.7B+21.6%
- FY1998$26.9B+13.8%
- FY1997$23.6B+19.2%
- FY1996$19.8B+18.9%
- FY1995$16.7B+11.4%
- FY1994$15B+42.6%
- FY1993$10.5B+8.6%
- FY1992$9.66B+12.3%
- FY1991$8.6B+12.1%
- FY1990$7.67B+17.1%
- FY1989$6.55B+10.3%
- FY1988$5.94B+17.4%
- FY1987$5.06B+22.6%
- FY1986$4.13B+16.4%
- FY1985$3.55B—
Revenue values are taken from Merck & Co.'s reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Merck & Co. (MRK)
According to Merck & Co.'s latest reported financial statements, the company's current revenue (TTM) is $65.6B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Merck & Co. (MRK) revenue totalled $64.9B – edged up 1.2% year-over-year.
Through 2020–2025 (5 years), Merck & Co. revenue delivered a +9.4% annualised rate; sustaining 6 straight years of year-over-year growth.
2025 marks the peak revenue at $64.9B, with the historical low of $3.55B recorded in 1985.
Merck & Co. Revenue by Year
Merck & Co. Revenue 2025: $64.9B
2025's revenue for Merck & Co. came in at $64.9B, edged up 1.2% from 2024. This figure represents the highest annual value in the available history.
Merck & Co. Revenue 2024: $64.2B
Merck & Co. posted revenue of $64.2B in 2024, grew 6.7% from 2023.
Merck & Co. Revenue 2023: $60.1B
In 2023, Merck & Co. reported revenue of $60.1B, edged up 1.4% from 2022.
Merck & Co. Revenue 2022: $59.3B
Merck & Co. revenue in 2022 was $59.3B, grew 21.7% from 2021.
Merck & Co. Revenue 2021: $48.7B
Merck & Co. revenue in 2021 was $48.7B.
See more financial history for Merck & Co. (MRK).
Sector peers by Revenue
Healthcare peers of Merck & Co. (MRK), ranked by their latest revenue
| $448B | |
| $94.2B | |
| $65.2B | |
| $61.2B | |
| $48.2B | |
| $44.6B | |
| $44.3B | |
| $36.7B |
- $94.2B
- $65.2B
- $61.2B
- $48.2B
- $36.7B
Frequently asked questions
Merck & Co. (MRK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.00% TTM
- Dividend Profile2.58% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History7 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.